Company
overview

Proteus Genomics is a highly-specialized, ground-breaking, genetic, and microbiology laboratory. We are the market leader in providing targeted, molecular diagnostics, focused on developing solutions to improve clinical and economic outcomes.

Our distinct area of expertise is real-time quantitative reverse transcription polymerase chain reaction (RT qRT-PCR) and next generation DNA sequencing (NGS). Our high-complexity CLIA clinical reference scientists have developed an unparalleled suite of custom arrays. Proteus Genomics’ proprietary test panels include UTI, Respiratory, Wound, Women’s Health, and STI. These novel, custom test offerings provide our partner physicians and providers the broadest, clearest, actionable patient results, as powered by our pioneering Pro-Vision software.

Proteus Genomics is driven by a simple mission: precision-guided, patient-focused.  Enabling us to deliver our providers and health systems enhanced, unrivaled treatment visibility.

Quality: We use the highest performance standards in the industry. Our customers entrust us to deliver results that can impact patient care and outcomes.

Innovation: We employ innovative solutions to help our customers adapt and meet the ever changing needs of the healthcare environment.

Vision: We recognize the importance of being highly efficient and cost sensitive in our services in order to bring a unique value proposition to our customers.